Cargando…

Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure

BACKGROUND: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. METHODS AND RESULTS: We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Eapen, Zubin J., Hammill, Bradley G., Setoguchi, Soko, Schulman, Kevin A., Peterson, Eric D., Hernandez, Adrian F., Curtis, Lesley H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835226/
https://www.ncbi.nlm.nih.gov/pubmed/24025363
http://dx.doi.org/10.1161/JAHA.113.000242
_version_ 1782292119760666624
author Eapen, Zubin J.
Hammill, Bradley G.
Setoguchi, Soko
Schulman, Kevin A.
Peterson, Eric D.
Hernandez, Adrian F.
Curtis, Lesley H.
author_facet Eapen, Zubin J.
Hammill, Bradley G.
Setoguchi, Soko
Schulman, Kevin A.
Peterson, Eric D.
Hernandez, Adrian F.
Curtis, Lesley H.
author_sort Eapen, Zubin J.
collection PubMed
description BACKGROUND: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. METHODS AND RESULTS: We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, β‐blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap. CONCLUSIONS: Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure.
format Online
Article
Text
id pubmed-3835226
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-38352262013-11-25 Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure Eapen, Zubin J. Hammill, Bradley G. Setoguchi, Soko Schulman, Kevin A. Peterson, Eric D. Hernandez, Adrian F. Curtis, Lesley H. J Am Heart Assoc Original Research BACKGROUND: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. METHODS AND RESULTS: We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers, β‐blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap. CONCLUSIONS: Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure. Blackwell Publishing Ltd 2013-10-25 /pmc/articles/PMC3835226/ /pubmed/24025363 http://dx.doi.org/10.1161/JAHA.113.000242 Text en © 2013 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Eapen, Zubin J.
Hammill, Bradley G.
Setoguchi, Soko
Schulman, Kevin A.
Peterson, Eric D.
Hernandez, Adrian F.
Curtis, Lesley H.
Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
title Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
title_full Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
title_fullStr Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
title_full_unstemmed Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
title_short Who Enrolls in the Medicare Part D Prescription Drug Benefit Program? Medication Use Among Patients With Heart Failure
title_sort who enrolls in the medicare part d prescription drug benefit program? medication use among patients with heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835226/
https://www.ncbi.nlm.nih.gov/pubmed/24025363
http://dx.doi.org/10.1161/JAHA.113.000242
work_keys_str_mv AT eapenzubinj whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure
AT hammillbradleyg whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure
AT setoguchisoko whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure
AT schulmankevina whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure
AT petersonericd whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure
AT hernandezadrianf whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure
AT curtislesleyh whoenrollsinthemedicarepartdprescriptiondrugbenefitprogrammedicationuseamongpatientswithheartfailure